Ronnie Cowan MP
I am delighted to be having this debate, and I congratulate the hon. Member for Barnsley Central (Dan Jarvis) on securing it. He told us the moving stories of Max and Joe, bringing a human aspect to the debate. He underlined that deaths are preventable, but that although 66% of people in England would donate, only 39% are on the donor register. Combined with the knowledge that only a small number of people on the register of donors will be able to donate, that highlights the fact that there is clearly a lot of work to be done.
The hon. Member for Congleton (Fiona Bruce) added a few notes of caution, with the view of aiding an informed debate. There are always at least two sides to a debate, and being informed does us no harm. Unfortunately, she is no longer in her seat to hear me say so; to me, hanging on for an entire debate is important.
The hon. Member for Newport West (Paul Flynn), speaking in his own inimitable style and even summing up the debate for me at one stage, told the story of Matthew, a 22-year-old man who unfortunately lost his life, and the feeling that had a system been in place back then, an operation could have been available and his life might have been saved. The hon. Gentleman also urged England to follow Wales’s lead by implementing a soft opt-out scheme.
The hon. Member for Strangford (Jim Shannon) spoke about his nephew Peter, who required a kidney and fortunately got one, and is alive today due to that donation. Not everyone in Northern Ireland has been as fortunate. He also highlighted that one donor can save multiple lives.
The hon. Member for Bristol East (Kerry McCarthy) spoke about missed targets, saying that no plan is perfect, which reminded me of the Churchill quote:
“Perfection is the enemy of progress.”
She also spoke passionately about the needs of those with cystic fibrosis.
There were a few false starts, but now that the Welsh Government’s soft opt-out is up and running, the Scottish Government have announced plans to do the same thing. An independent evaluation of the implementation of the Welsh opt-out system is due to be published in December 2017, and we believe that the numbers will be encouraging, but if even one donor has been identified, it must be worth it. The British Medical Association has stated that it believes that over time, an opt-out scheme promotes more positive social attitudes to donations, so it may well be that we will not see the benefits for a few years to come.
I believe that the most important people in this debate are the many waiting for a donor—those whose lives are poorer or even on the line as they wait, and wait. This is not solely about saving lives; it is about improving them. One donation does not simply save or improve one life; it has a knock-on effect. My colleague Iain Fraser would not have been born if his father Sandy had not received a kidney many years ago. I thank Sandy Fraser for his ongoing commitment and work in his capacity as the chairman of the Scottish Kidney Federation.
I ask Members: if they had a loved one, as many of us do, whose life could be transformed by receiving an organ donation, would they not turn over every single stone and investigate every possibility in order to identify a donor? I hope that is what we are about to do. In my view, a soft opt-out scheme is the path to go down, but whatever comes of this debate, it must stimulate discussion. We should all make our wishes known to our friends and family. When my time comes, as it will, please take whatever you want.